cagrisema cagrilintide semaglutide phase 3 obesity is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had ≥1 weight-related complication, individuals assigned to a combination Three new phase 3 REIMAGINE
Description
The term lipotropic literally means fat-loving, referring to compounds that promote the transport, breakdown, and removal of fat from the liver
NEJM 2025 (REDEFINE-2) Novo Nordisk FDA NDA submission announcement (December 18, 2025) Eli Lilly TRIUMPH-4 topline results (December 2025) Frequently Asked Questions Retatrutide produces higher weight loss at 28.7% versus CagriSema's 20.4%a difference of 21 pounds for a 250-pound person
Finnish sauna research, drawn from large population cohorts, has shown that sauna bathing four to seven times per week is associated with a 66 percent reduction in dementia risk
It is an 83-amino-acid peptide bearing an arginine substitution at position 3 and a 13-amino-acid extension at the N-terminus
Its value is in what it adds when combined with GLP-1 agonism
